Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02312557
Brief Title: Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide

First Submitted : December 4, 2014
First Submitted that Met QC Criteria : December 4, 2014
First Posted : December 9, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : May 13, 2021
Last Update Posted : May 17, 2021